Physician

Jason Noble

According to 2025 Medicare claims, Jason Noble (NPI: 1487853735) practices dermatology in the Rapid City, SD market, with the plurality of this provider's patient population coming from Pennington, SD. This provider's primary affiliated billing organization is RAPID CITY MEDICAL CENTER, LLP (NPI: 1487602843; TIN: 460218851) and primary practice location at 57701-5462. Noble is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and On Belay Health Solutions (ACO ID: A5702), participating under the MSSP model.

Noble's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,065 traditional Medicare patients, billed 7,526 HCPCS/CPT codes, and received $270,566 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 667 prescription claims across 365 beneficiaries totaling $52,369 in drug costs, led by Ketoconazole (Ketoconazole). Open Payments data shows 25 records totaling $481. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $30,446 to $52,369. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$161K$322K2015 Medicare payment: $268,365 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $271,588 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $308,102 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $303,857 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $306,880 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $254,828 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $322,350 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $263,116 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $266,812 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $270,566 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0047,941$268,365
20161,0148,331$271,588
20171,1228,796$308,102
20181,1599,054$303,857
20191,2008,018$306,880
20201,1177,243$254,828
20211,3518,348$322,350
20221,2887,483$263,116
20231,2457,386$266,812
20241,0657,526$270,566

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$56K$112K2015 Drug cost: $30,446 (USD; Tot_Drug_Cst)2016 Drug cost: $29,289 (USD; Tot_Drug_Cst)2017 Drug cost: $36,808 (USD; Tot_Drug_Cst)2018 Drug cost: $65,374 (USD; Tot_Drug_Cst)2019 Drug cost: $112,132 (USD; Tot_Drug_Cst)2020 Drug cost: $43,047 (USD; Tot_Drug_Cst)2021 Drug cost: $79,133 (USD; Tot_Drug_Cst)2022 Drug cost: $75,305 (USD; Tot_Drug_Cst)2023 Drug cost: $51,303 (USD; Tot_Drug_Cst)2024 Drug cost: $52,369 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015264554$30,446
2016302558$29,289
2017292549$36,808
2018285592$65,374
2019322680$112,132
2020308602$43,047
2021321613$79,133
2022255492$75,305
2023297607$51,303
2024365667$52,369

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth373453$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8061,129$55
17000Destruction of precancer skin growth, 1 growth673944$34
88305Pathology examination of tissue using a microscope, intermediate complexity424960$27
17003Destruction of precancer skin growth, 2-14 growths5242,684$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KetoconazoleKetoconazole1874,107$2,476
FluocinonideFluocinonide631,030$1,675
MetronidazoleMetronidazole321,036$1,529
FluorouracilFluorouracil19472$1,193
TacrolimusTacrolimus11269$1,019

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$481ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jason Noble?

Tedicare shows public-source Medicare data for Jason Noble (NPI 1487853735), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Noble have ACO affiliation data?

Jason Noble is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and On Belay Health Solutions (MSSP, ACO ID A5702).

What billing organization is linked to Jason Noble?

Jason Noble is linked to RAPID CITY MEDICAL CENTER, LLP (billing NPI 1487602843) in the available physician profile data.

Does Jason Noble have Open Payments data?

Jason Noble has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.